- Home
- APLM vs ZAPP Comparison
APLM vs ZAPP Comparison
Compare APLM & ZAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- ZAPP
- Stock Information
- Founded
- APLM 2016
- ZAPP 2017
- Country
- APLM United States
- ZAPP Thailand
- Employees
- APLM N/A
- ZAPP N/A
- Industry
- APLM Blank Checks
- ZAPP Motor Vehicles
- Sector
- APLM Finance
- ZAPP Consumer Discretionary
- Exchange
- APLM Nasdaq
- ZAPP Nasdaq
- Market Cap
- APLM 15.6M
- ZAPP 13.5M
- IPO Year
- APLM N/A
- ZAPP N/A
- Fundamental
- Price
- APLM $0.13
- ZAPP $2.65
- Analyst Decision
- APLM Strong Buy
- ZAPP
- Analyst Count
- APLM 2
- ZAPP 0
- Target Price
- APLM $4.25
- ZAPP N/A
- AVG Volume (30 Days)
- APLM 872.1K
- ZAPP 117.6K
- Earning Date
- APLM 08-14-2024
- ZAPP 11-01-2024
- Dividend Yield
- APLM N/A
- ZAPP N/A
- EPS Growth
- APLM N/A
- ZAPP N/A
- EPS
- APLM N/A
- ZAPP N/A
- Revenue
- APLM $2,101,000.00
- ZAPP N/A
- Revenue This Year
- APLM N/A
- ZAPP N/A
- Revenue Next Year
- APLM N/A
- ZAPP $41,300.00
- P/E Ratio
- APLM N/A
- ZAPP N/A
- Revenue Growth
- APLM 70.54
- ZAPP N/A
- 52 Week Low
- APLM $0.11
- ZAPP $0.70
- 52 Week High
- APLM $2.15
- ZAPP $19.10
- Technical
- Relative Strength Index (RSI)
- APLM 45.47
- ZAPP 35.93
- Support Level
- APLM $0.13
- ZAPP $2.56
- Resistance Level
- APLM $0.17
- ZAPP $3.20
- Average True Range (ATR)
- APLM 0.01
- ZAPP 0.21
- MACD
- APLM 0.00
- ZAPP 0.09
- Stochastic Oscillator
- APLM 26.03
- ZAPP 20.47
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About ZAPP Zapp Electric Vehicles Group Limited
Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories.